Company Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.
It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products.
The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.
It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups.
The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015.
Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Country | United States |
IPO Date | Jul 25, 2001 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 18,000 |
CEO | Ivan Tornos |
Contact Details
Address: 345 East Main Street Warsaw, Indiana United States | |
Website | https://www.zimmerbiomet.com |
Stock Details
Ticker Symbol | ZBH |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001136869 |
CUSIP Number | 98956P102 |
ISIN Number | US98956P1021 |
Employer ID | 13-4151777 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Ivan Tornos | Chief Operating Officer, President, Chief Executive Officer & Director |
Suketu P. Upadhyay | Chief Financial Officer and Executive Vice President of Finance, Operations & Supply Chain |
Angela Main | Senior Vice President, Global Chief Compliance Officer & Associate General Counsel of Asia Pacific |
Chad F. Phipps J.D. | Senior Vice President, General Counsel & Secretary |
David M. DeMartino | Senior Vice President of Investor Relations |
Paul A. Stellato | Vice President, Controller & Chief Accounting Officer |
Rachel H. Ellingson | Senior Vice President & Chief Administrative Officer |
Sang Yi | President of Asia Pacific |
Shaun Braun | Senior Vice President & Chief Information and Technology Officer |
Wilfred van Zuilen | Group President of Europe, Middle East & Africa |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 22, 2024 | CERT | Filing |
Nov 20, 2024 | 8-A12B | Filing |
Nov 20, 2024 | 8-K | Current Report |
Nov 19, 2024 | 8-K | Current Report |
Nov 14, 2024 | 424B5 | Filing |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 13, 2024 | FWP | Filing |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 13, 2024 | 424B5 | Filing |
Nov 12, 2024 | 4 | Filing |